NEW YORK (GenomeWeb) – MDxHealth announced today that it has partnered with the Andros Men's Health Clinic in the Netherlands to offer its SelectMDx liquid biopsy prostate cancer test to Andros' patients.

Under the terms of the deal, the clinic will offer the diagnostic to all patients considered at risk for prostate cancer, with over 500 patients to undergo testing in the first year of the partnership. SelectMDx will become available starting April 1.

Further terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.